by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Pharmathen International S.A. Warning Letter Details

Warning Letter

Pharmathen International S.A.

44 Kifissias Ave. 15125 Marousi Attica Greece

Issue DateMay 27, 2026

FEI Number3009961173

Violations5

CountryGreece

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Pharmathen International S.A. FDA Warning Letter, May 27, 2026